Laboratory diagnosis of lupus anticoagulants: Effect of residual platelets in plasma, assessed by Staclot® LA and silica clotting time

Thrombosis and Haemostasis

Volumn 87, Issue 5, 2002, Pages 854-858

  Chantarangkul, Veena ^a   Tripodi, Armando ^a   Clerici, Marigrazia ^a   Bressi, Caterina ^a   Mannucci, Pier Mannuccio ^a  

^a NONE   (Italy)

Author keywords

Lupus anticoagulant; Screening; Standardization; Thrombophilia

Indexed keywords

LUPUS ANTICOAGULANT; PHOSPHOLIPID DERIVATIVE; SILICONE; STACLOT;

ARTICLE; BLOOD CLOTTING TIME; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FREEZING; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PLASMA; PRIORITY JOURNAL; SCREENING; STANDARDIZATION; THAWING; THROMBOCYTE; THROMBOSIS;

EID: 0036256874     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613096     Document Type: Article

References (17)

1. Antiphospholipid-protein antibodies: Laboratory detection and clinical relevance
2. Antiphospholipid antibody syndrome: Diagnostic aspects of Lupus Anticoagulants
3. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants
4. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus. A meta-analysis
5. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis
6. Antiphospholipid antibodies and beta2-glycoprotein I in 500 women with recurrent miscarriage: Results of a comprehensive screening approach
7. Laboratory investigation of thrombophilia
8. Guidelines on the investigation and management of the antiphospholipid syndrome
9. Investigation of the lupus-like inhibitory by-passing activity of platelets
10. Preparation of plasma for the detection of lupus anticoagulants and antiphospholipid antibodies
11. Detection of lupus anticoagulant: An evaluation of routines for preparation and storage of plasma
12. Lupus anticoagulant testing: Effect of platelet count on the activated partial thromboplastin time
13. Criteria for the diagnosis of lupus anticoagulants: An update
14. Silica clotting time (SCT) as a screening and confirmatory test for detection of the lupus anticoagulants
15. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification
16. Guidelines for testing and revised criteria for lupus anticoagulants
17. Quantification of lupus anticoagulants in clinical samples using anti-beta 2GPI and antiprothrombin monoclonal antibodies